FDA’s NAM framework emphasizes context of use, human biological relevance, technical characterization, and fit-for-purpose ...
GlobalData on MSN
Simulations Plus and three pharma companies collaborate on AI-driven drug development
The collaborations will use Simulations Plus software platforms, including ADMET Predictor, GastroPlus, Thales, and ...
Gilgamesh Pharma, a clinical-stage neuroscience company developing breakthrough therapies for psychiatric and neurological disorders, today announced the successful closing of a $60 million Series A ...
TOKYO & PRINCETON, N.J.--(BUSINESS WIRE)--Otsuka Pharmaceutical Co., Ltd. (Otsuka) and its U.S. subsidiary, Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) announce termination of ...
Overall, the top 16 largest pharmaceutical companies spent $159 billion on research and development in 2025, compared to $165 ...
F rom blockbuster drugs that garner media attention to smaller innovations that help millions maintain health, the biotech and pharmaceutical industries have an impact on everyone’s life. Meanwhile, ...
Dynamic Vapor Sorption (DVS) is a potent analytical technique used in the pharmaceutical industry to determine how much vapor a sample absorbs or desorbed under regulated temperature and humidity ...
As pharmaceutical companies lean more heavily on A.I. to accelerate drug discovery, model biological interactions and ...
The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...
Results validate dose selection and de-risk pivotal trial in US and Europe clinical development program ...
Phlow Corp., a leading American advanced pharmaceutical contract development and manufacturing organization (CDMO), today announced that Dawn Von Rohr has been appointed Chief Operating Officer (COO).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results